toll-like receptor 7/8 agonist bdb018
Generic: Toll-like Receptor 7/8 Agonist BDB018
toll-like receptor 7/8 agonist bdb018: 1 clinical trial tracked.
toll-like receptor 7/8 agonist bdb018 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about toll-like receptor 7/8 agonist bdb018, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
Phase 1 Open-Label Dose Escalation Study of BDB001 as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Primary endpoint: Safety and Tolerability: incidence of adverse events and any dose limiting toxicity
Interventionalopen1 enrolledStarted 2021-06Completion 2024-093 sites · United StatesEikon Therapeutics